2 documents found

Article / Chapter
CC BY-NC-ND 3.0
2018

Serum Inflammatory Profile for the Discrimination of Clinical Subtypes...

Background: Blood levels of immune markers have been proposed to discriminate patients with Parkinson's disease (PD) from controls. However, differences between clinical PD subgroups regarding these markers still need to be identified. Objective: To investigate whether clinical phenotypes can be predicted...
Lausanne: Frontiers Media SA, 2018
Article / Chapter
CC BY-NC-ND 3.0
2016

GDF15/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson’s Disease and...

Based on animal and ex-vivo experiments, Growth/Differentiation Factor-15 (GDF15, also called Macrophage Inhibitory Cytokine-1, MIC1), a member of the transforming growth factor-beta family, and Matrix Metalloproteinase-9 (MMP9), a member of the matrix metalloprotease family may be potential markers...
San Francisco: PloS one, 2016